Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CEO
MedTech
Stan Bergman to retire after 35 years as CEO of Henry Schein
Since becoming CEO in 1989, the medical and dental supply maker has seen annual revenues grow from $225 million to $12.7 billion in 2024.
Conor Hale
Jul 15, 2025 11:00am
Baxter taps new CEO as it emerges from years-long restructuring
Jul 7, 2025 10:30am
Miniature robot maker Virtual Incision nabs new CEO
Jun 20, 2025 11:03am
Fierce Pharma
Novo's longtime CEO Lars Fruergaard Jørgensen to step down
May 16, 2025 9:41am
Insulet taps former J&J medtech head Ashley McEvoy to be CEO
Apr 28, 2025 11:00am
Avanos taps Siemens Healthineers' Americas president as CEO
Mar 17, 2025 11:26am
